Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

Clinical trial NCT07220993 · RECRUITING

Trial details

NCT number: NCT07220993
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Lymphoma T-non-Hodgkin Lymphoma T-cell Acute Lymphoblastic Leukemia

Start date: 2026-05-12
Primary completion: 2028-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.